Results from the 6-month STELVIO trial validated the safety and efficacy of the Pulmonx Zephyr Endobronchial Valve (EBV) in severe emphysema patients.
Regular aspirin use was associated with a significantly slower progression of percent emphysema over 10 years, when compared to those who did not use aspirin.
Treatment of COPD with inhaled corticosteroids may decrease the risk of dying from pneumonia despite being linked with an increase in pneumonia occurrence.
In a study of 2,489 adults with COPD, gastroesophageal reflux disease (GERD), certain scores on the St. George’s Respiratory Questionnaire (SGRQ), and being female were specific risk factors associated with exacerbations of COPD in participants using long-acting controller medication.
Spyryx Biosciences, Inc, has raised $18 million in financing, which will be used to develop therapies to treat respiratory conditions including cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD).
Anemia reduces exercise capacity and negatively impacts quality of life in patients with COPD, according to study results.
Lung volume reduction surgery (LVRS), a surgical treatment option for emphysema, was shown to have durable benefits in the National Emphysema Treatment Trial (NETT).
A European Medicines Agency's (EMA) committee has launched a review of pneumonia risk for inhaled corticosteroid-containing medicines used to treat COPD.
Using the fixed-dose combination aclidinium bromide/formoterol resulted in added benefits for some COPD patients with grade II and grade III stages of the disease.
A recent report shows a need for improvement in COPD management in individuals living in the Asia-Pacific region.
Nonin Medical has announced a partnership with IDEAL Life, a Toronto-based provider of remote health management solutions.
The Sentrian Remote Patient Intelligence platform uses biosensors to monitor patients remotely, but the company uses machine learning to customize the alert parameters for each patient.
A new study implicates a specific mitochondrial protein and pathway in the development of COPD from exposure to cigarette smoke.
Researchers at the University of Alabama at Birmingham have obtained an $11 million grant from the Department of Defense to study the role of beta blockers in patients with COPD.
Effective pulmonary function tests on their own, combining the diagnostic power of spirometry and plethysmography gives clinicians a frontline weapon in the management of chronic lung diseases like asthma and COPD.
Persons with COPD and high blood eosinophil can significantly benefit from the use of inhaled corticosteroids, according to a recent study.
Novartis has plans to roll out the Volari COPD app to 10 countries this year. The app intends to improve patient-physician communication.
A biotech company has developed a method to extract the needed Alpha-1 Antitrypsin (AAT) for the treatment of the genetic type of COPD.
A research group in Korea has reported a higher prevalence of vitamin D deficiency in individuals with COPD.
The AARC has asked respiratory therapists in Texas to support an initiative that would establish a strategic plan for asthma and COPD.